EKSO: Ekso Bionics Holdings Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Ekso Bionics Holdings Inc (EKSO).
$13.42M Market Cap.
EKSO Market Cap. (MRY)
EKSO Shares Outstanding (MRY)
EKSO Assets (MRY)
Total Assets
$26.65M
Total Liabilities
$13.95M
Total Investments
$0
EKSO Income (MRY)
Revenue
$17.93M
Net Income
-$11.33M
Operating Expense
$19.97M
EKSO Cash Flow (MRY)
CF Operations
-$9.85M
CF Investing
-$37.00K
CF Financing
$7.77M
EKSO Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $26,652,000 (-7.84%) | $28,918,000 (-29.30%) | $40,903,000 (-16.81%) | $49,166,000 (138.70%) |
Assets Current | $18,843,000 (-6.75%) | $20,208,000 (-34.89%) | $31,037,000 (-35.06%) | $47,795,000 (159.47%) |
Assets Non-Current | $7,809,000 (-10.34%) | $8,710,000 (-11.72%) | $9,866,000 (619.62%) | $1,371,000 (-37.02%) |
Goodwill & Intangible Assets | $5,011,000 (-5.86%) | $5,323,000 (-5.75%) | $5,648,000 (0%) | $0 (0%) |
Shareholders Equity | $12,707,000 (0.80%) | $12,606,000 (-50.45%) | $25,442,000 (-31.64%) | $37,219,000 (739.40%) |
Property Plant & Equipment Net | $2,365,000 (-21.04%) | $2,995,000 (-24.88%) | $3,987,000 (230.32%) | $1,207,000 (-35.00%) |
Cash & Equivalents | $6,493,000 (-24.83%) | $8,638,000 (-57.91%) | $20,525,000 (-49.20%) | $40,406,000 (214.15%) |
Accumulated Other Comprehensive Income | $957,000 (513.46%) | $156,000 (-72.29%) | $563,000 (3411.76%) | -$17,000 (97.99%) |
Deferred Revenue | $3,876,000 (-6.87%) | $4,162,000 (93.31%) | $2,153,000 (-20.11%) | $2,695,000 (-18.38%) |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $4,571,000 (-9.49%) | $5,050,000 (-2.64%) | $5,187,000 (131.36%) | $2,242,000 (13.35%) |
Trade & Non-Trade Receivables | $7,238,000 (28.22%) | $5,645,000 (22.05%) | $4,625,000 (-0.79%) | $4,662,000 (44.60%) |
Trade & Non-Trade Payables | $1,552,000 (-15.97%) | $1,847,000 (-41.38%) | $3,151,000 (1.42%) | $3,107,000 (107.00%) |
Accumulated Retained Earnings (Deficit) | -$250,475,000 (-4.74%) | -$239,145,000 (-6.79%) | -$223,947,000 (-7.22%) | -$208,867,000 (-4.90%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $5,983,000 (-16.53%) | $7,168,000 (-4.49%) | $7,505,000 (237.76%) | $2,222,000 (-42.38%) |
Debt Current | $1,677,000 (3.97%) | $1,613,000 (-39.16%) | $2,651,000 (1057.64%) | $229,000 (-58.21%) |
Debt Non-Current | $4,306,000 (-22.48%) | $5,555,000 (14.44%) | $4,854,000 (143.55%) | $1,993,000 (-39.75%) |
Total Liabilities | $13,945,000 (-14.51%) | $16,312,000 (5.50%) | $15,461,000 (29.41%) | $11,947,000 (-26.08%) |
Liabilities Current | $7,537,000 (-7.15%) | $8,117,000 (-11.78%) | $9,201,000 (34.22%) | $6,855,000 (37.82%) |
Liabilities Non-Current | $6,408,000 (-21.81%) | $8,195,000 (30.91%) | $6,260,000 (22.94%) | $5,092,000 (-54.49%) |
EKSO Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $17,925,000 (-1.94%) | $18,279,000 (41.57%) | $12,912,000 (14.81%) | $11,246,000 (26.62%) |
Cost of Revenue | $8,414,000 (-8.54%) | $9,200,000 (37.35%) | $6,698,000 (48.94%) | $4,497,000 (17.97%) |
Selling General & Administrative Expense | $16,097,000 (-16.01%) | $19,166,000 (5.63%) | $18,144,000 (0.64%) | $18,028,000 (16.66%) |
Research & Development Expense | $3,874,000 (-22.91%) | $5,025,000 (38.58%) | $3,626,000 (42.25%) | $2,549,000 (3.03%) |
Operating Expenses | $19,971,000 (-17.44%) | $24,191,000 (11.12%) | $21,770,000 (5.80%) | $20,577,000 (12.07%) |
Interest Expense | $269,000 (-10.93%) | $302,000 (93.59%) | $156,000 (38.05%) | $113,000 (-18.71%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$11,330,000 (25.45%) | -$15,198,000 (-0.78%) | -$15,080,000 (-54.44%) | -$9,764,000 (38.30%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$11,330,000 (25.45%) | -$15,198,000 (-0.78%) | -$15,080,000 (-54.44%) | -$9,764,000 (38.30%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$11,330,000 (25.45%) | -$15,198,000 (-0.78%) | -$15,080,000 (-54.44%) | -$9,764,000 (38.30%) |
Weighted Average Shares | $20,161,000 (45.39%) | $13,867,000 (6.98%) | $12,962,000 (6.31%) | $12,193,000 (70.20%) |
Weighted Average Shares Diluted | $20,161,000 (45.39%) | $13,867,000 (6.98%) | $12,962,000 (5.65%) | $12,269,000 (71.26%) |
Earning Before Interest & Taxes (EBIT) | -$11,061,000 (25.75%) | -$14,896,000 (0.19%) | -$14,924,000 (-54.64%) | -$9,651,000 (38.47%) |
Gross Profit | $9,511,000 (4.76%) | $9,079,000 (46.11%) | $6,214,000 (-7.93%) | $6,749,000 (33.12%) |
Operating Income | -$10,460,000 (30.78%) | -$15,112,000 (2.85%) | -$15,556,000 (-12.50%) | -$13,828,000 (-4.04%) |
EKSO Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$37,000 (76.43%) | -$157,000 (96.97%) | -$5,175,000 (-8671.19%) | -$59,000 (0%) |
Net Cash Flow from Financing | $7,769,000 (2132.47%) | $348,000 (0%) | $0 (0%) | $38,712,000 (261.66%) |
Net Cash Flow from Operations | -$9,846,000 (18.32%) | -$12,054,000 (17.93%) | -$14,688,000 (-31.66%) | -$11,156,000 (-27.42%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$2,145,000 (81.96%) | -$11,887,000 (40.21%) | -$19,881,000 (-172.18%) | $27,544,000 (1284.12%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | -$5,000,000 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | -$37,000 (76.43%) | -$157,000 (10.29%) | -$175,000 (-196.61%) | -$59,000 (0%) |
Issuance (Repayment) of Debt Securities | -$1,250,000 (-299.36%) | -$313,000 (0%) | $0 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $9,019,000 (1264.45%) | $661,000 (0%) | $0 (0%) | $38,712,000 (271.66%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | -$31,000 (-29.17%) | -$24,000 (-33.33%) | -$18,000 (-138.30%) | $47,000 (14.63%) |
Share Based Compensation | $1,373,000 (-26.10%) | $1,858,000 (-27.02%) | $2,546,000 (9.32%) | $2,329,000 (-3.36%) |
Depreciation Amortization & Accretion | $1,608,000 (-5.30%) | $1,698,000 (91.43%) | $887,000 (-13.29%) | $1,023,000 (65.00%) |
EKSO Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 53.10% (6.84%) | 49.70% (3.33%) | 48.10% (-19.83%) | 60.00% (5.08%) |
Profit Margin | -63.20% (23.95%) | -83.10% (28.85%) | -116.80% (-34.56%) | -86.80% (51.29%) |
EBITDA Margin | -52.70% (27.01%) | -72.20% (33.58%) | -108.70% (-41.72%) | -76.70% (54.78%) |
Return on Average Equity (ROAE) | -84.40% (7.05%) | -90.80% (-79.45%) | -50.60% (-104.03%) | -24.80% (92.93%) |
Return on Average Assets (ROAA) | -40.50% (12.53%) | -46.30% (-26.50%) | -36.60% (-95.72%) | -18.70% (75.36%) |
Return on Sales (ROS) | -61.70% (24.29%) | -81.50% (29.50%) | -115.60% (-34.73%) | -85.80% (51.42%) |
Return on Invested Capital (ROIC) | -76.80% (28.76%) | -107.80% (47.90%) | -206.90% (-0.10%) | -206.70% (21.94%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -1.09 (52.09%) | -2.27 (-121.54%) | -1.03 (69.02%) | -3.31 (-19.39%) |
Price to Sales Ratio (P/S) | 0.69 (-63.84%) | 1.9 (58.74%) | 1.2 (-58.41%) | 2.87 (-41.89%) |
Price to Book Ratio (P/B) | 1.06 (-62.59%) | 2.82 (359.02%) | 0.61 (-31.82%) | 0.9 (-92.15%) |
Debt to Equity Ratio (D/E) | 1.1 (-15.22%) | 1.29 (112.83%) | 0.61 (89.41%) | 0.32 (-91.19%) |
Earnings Per Share (EPS) | -0.56 (49.09%) | -1.1 (5.17%) | -1.16 (-45.00%) | -0.8 (63.80%) |
Sales Per Share (SPS) | 0.89 (-32.55%) | 1.32 (32.33%) | 1 (8.03%) | 0.92 (-25.65%) |
Free Cash Flow Per Share (FCFPS) | -0.49 (44.38%) | -0.88 (23.19%) | -1.15 (-24.67%) | -0.92 (24.71%) |
Book Value Per Share (BVPS) | 0.63 (-30.69%) | 0.91 (-53.69%) | 1.96 (-35.68%) | 3.05 (393.05%) |
Tangible Assets Book Value Per Share (TABVPS) | 1.07 (-36.96%) | 1.7 (-37.43%) | 2.72 (-32.54%) | 4.03 (40.24%) |
Enterprise Value Over EBIT (EV/EBIT) | -1 (50.00%) | -2 (-300.00%) | 1 (0.00%) | 1 (133.33%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -1.21 (51.65%) | -2.51 (-447.78%) | 0.72 (-17.11%) | 0.87 (132.57%) |
Asset Turnover | 0.64 (15.08%) | 0.56 (77.96%) | 0.31 (45.58%) | 0.21 (-49.53%) |
Current Ratio | 2.5 (0.40%) | 2.49 (-26.18%) | 3.37 (-51.62%) | 6.97 (88.28%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$9,883,000 (19.06%) | -$12,211,000 (17.84%) | -$14,863,000 (-32.53%) | -$11,215,000 (-28.10%) |
Enterprise Value (EV) | $11,473,005 (-65.37%) | $33,134,045 (426.97%) | -$10,133,523 (-34.82%) | -$7,516,150 (-118.66%) |
Earnings Before Tax (EBT) | -$11,330,000 (25.45%) | -$15,198,000 (-0.78%) | -$15,080,000 (-54.44%) | -$9,764,000 (38.30%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$9,453,000 (28.38%) | -$13,198,000 (5.98%) | -$14,037,000 (-62.69%) | -$8,628,000 (42.73%) |
Invested Capital | $13,594,000 (-2.96%) | $14,008,000 (7.47%) | $13,034,000 (215.82%) | $4,127,000 (-37.63%) |
Working Capital | $11,306,000 (-6.49%) | $12,091,000 (-44.63%) | $21,836,000 (-46.66%) | $40,940,000 (204.48%) |
Tangible Asset Value | $21,641,000 (-8.28%) | $23,595,000 (-33.07%) | $35,255,000 (-28.29%) | $49,166,000 (138.70%) |
Market Capitalization | $13,419,005 (-62.29%) | $35,587,045 (127.55%) | $15,639,477 (-53.40%) | $33,558,850 (-34.17%) |
Average Equity | $13,421,750 (-19.81%) | $16,738,250 (-43.86%) | $29,817,750 (-24.20%) | $39,338,000 (772.48%) |
Average Assets | $27,950,500 (-14.78%) | $32,797,750 (-20.48%) | $41,244,000 (-21.21%) | $52,344,000 (151.12%) |
Invested Capital Average | $14,404,000 (4.19%) | $13,824,500 (91.67%) | $7,212,500 (54.48%) | $4,668,750 (-21.18%) |
Shares | 21,998,369 (54.54%) | 14,234,818 (8.31%) | 13,142,418 (3.78%) | 12,663,717 (52.28%) |
